Evidence map›Paper›PMID 30255291›Full record

ArticleEndocrine2019

Role of kisspeptin and Kiss1R in the regulation of prolactin gene expression in rat somatolactotroph GH3 cells.

Tomomi Hara, Haruhiko Kanasaki, Tuvshintugs Tumurbaatar, Aki Oride, Hiroe Okada, Satoru Kyo

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Current Insights in Prolactin Signaling and Ovulatory Function.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tomomi HaraDepartment of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, 693-8501, Japan.
Haruhiko KanasakiDepartment of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, 693-8501, Japan. kanasaki@med.shimane-u.ac.jp.
Tuvshintugs TumurbaatarDepartment of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, 693-8501, Japan.
Aki OrideDepartment of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, 693-8501, Japan.
Hiroe OkadaDepartment of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, 693-8501, Japan.
Satoru KyoDepartment of Obstetrics and Gynecology, Shimane University School of Medicine, Izumo, 693-8501, Japan.
Shimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypothalamic kisspeptin is a known principal activator of gonadotropin-releasing hormone neurons and governs the hypothalamic-pituitary-gonadal axis. Previous reports have shown that kisspeptin is also released into the hypophyseal portal circulation and directly affects the anterior pituitary. In this study, we examined the direct effect of kisspeptin on pituitary prolactin-producing cells. The rat pituitary somatolactotroph cell line GH3 expresses the kisspeptin receptor (Kiss1R); however, in these cells, kisspeptin failed to stimulate prolactin-promoter activity. When GH3 cells overexpressed Kiss1R, kisspeptin clearly increased prolactin-promoter activity, with a concomitant increase in extracellular signal-regulated kinase (ERK) and cAMP/protein kinase A (PKA) signaling pathways. In the experiments using GH3 cells overexpressing Kiss1R, kisspeptin did not potentiate thyrotropin-releasing hormone (TRH)-induced prolactin-promoter activity, but it potentiated the pituitary adenylate cyclase-activating polypeptide-induced prolactin-promoter activity, with a concomitant enhancement of ERK and PKA signaling pathways. Although the basal and TRH-induced prolactin-promoter activities were not modulated by increasing amounts of Kiss1R expression in GH3 cells, kisspeptin-stimulated prolactin-promoter activity was increased by the amount of Kiss1R overexpression. Endogenous Kiss1r mRNA expression in GH3 cells was significantly increased by treatment with estradiol (E2) but not by TRH. In addition, kisspeptin's ability to stimulate prolactin-promoter activity was restored after E2 treatment in non-transfected GH3 cells. Our current observations suggest that kisspeptin might have a direct effect on prolactin expression in the anterior pituitary prolactin-producing cells under the influence of E2, which may regulate Kiss1R expression and function.

Indexed as

AnimalsCell LineCyclic AMP-Dependent Protein KinasesEstradiolGene Expression RegulationHumansKisspeptinsMAP Kinase Signaling SystemPituitary Adenylate Cyclase-Activating PolypeptidePituitary GlandProlactinPromoter Regions, GeneticRatsReceptors, Kisspeptin-1Signal TransductionThyrotropin-Releasing HormoneCyclic AMP-Dependent Protein KinasesEstradiolKiss1r protein, ratKisspeptinsPituitary Adenylate Cyclase-Activating PolypeptideProlactinReceptors, Kisspeptin-1Thyrotropin-Releasing HormoneKiss1RKisspeptinPACAPProlactinTRH

Identifiers

PMID30255291
OpenAlexW2893041704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.